Sublimaze Side Effects
Generic name: fentanyl
Medically reviewed by Drugs.com. Last updated on Mar 14, 2025.
Note: This document provides detailed information about Sublimaze Side Effects associated with fentanyl. Some dosage forms listed on this page may not apply specifically to the brand name Sublimaze.
Applies to fentanyl: injection solution.
Other dosage forms:
Important warnings
This medicine can cause some serious health issues
Injection route (solution)
Fentanyl citrate injection is a Schedule II controlled substance with abuse liability similar to other opioid analgesics.
Assess risk prior to initiation and monitor for signs of misuse, abuse, and addiction during treatment.
Serious, life-threatening, or fatal respiratory depression may occur.
Monitor for respiratory depression, especially during initiation or following a dose increase.
Use with CYP3A4 inhibitors or inducers may change fentanyl plasma levels resulting in a fatal overdose and monitoring is recommended.
Concomitant use of opioids with benzodiazepines or other CNS depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death.
Reserve concomitant prescribing for patients with inadequate alternative treatment options, limit dosage and duration to the minimum required, and monitor for respiratory depression and sedation.
Precautions
It is very important that your doctor check you closely while you or your child are receiving this medicine. This will allow your doctor to see if the medicine is working properly and to decide if you should continue to receive it.
This medicine may cause a serious allergic reaction called anaphylaxis. Anaphylaxis can be life-threatening and requires immediate medical attention. Call your doctor right away if you or your child have a rash, itching, hoarseness, trouble breathing, trouble swallowing, or any swelling of your hands, face, or mouth while you are using this medicine.
Do not use too much of this medicine or use it more often than your doctor tells you to. This can be life-threatening. Symptoms of an overdose include: extreme dizziness or weakness, slow heartbeat or breathing, seizures, trouble breathing, and cold, clammy skin. Call your doctor right away if you notice these symptoms.
Dizziness, lightheadedness, or fainting may occur with this medicine, especially when you get up suddenly from a lying or sitting position. Getting up slowly may help lessen this problem. Also, lying down for a while may relieve the dizziness or lightheadedness.
This medicine will add to the effects of alcohol and other central nervous system (CNS) depressants. CNS depressants are medicines that slow down the nervous system, which may cause drowsiness or make you less alert. Some examples of CNS depressants are antihistamines or medicine for hay fever, allergies, or colds, sedatives, tranquilizers, or sleeping pills, prescription pain medicine or narcotics, barbiturates or seizure medicines, muscle relaxants, or anesthetics (numbing medicines), including some dental anesthetics. This effect may last for a few days after you stop using this medicine. Check with your medical doctor or dentist before taking any of the above while you or your child are receiving this medicine.
This medicine may cause sleep-related breathing problems (eg, sleep apnea, sleep-related hypoxemia). Your doctor may decrease your dose if you have sleep apnea (stop breathing for short periods during sleep) while using this medicine.
This medicine may make you dizzy, drowsy, confused, or disoriented. Make sure you know how you react to this medicine before you drive, use machines, or do anything else that could be dangerous if you are dizzy or not alert.
This medicine may be habit-forming. If you feel that the medicine is not working as well, do not use more than your prescribed dose. Call your doctor for instructions.
Using narcotics for a long time can cause severe constipation. To prevent this, your doctor may direct you to take laxatives, drink a lot of fluids, or increase the amount of fiber in your diet. Be sure to follow the directions carefully, because continuing constipation can lead to more serious problems.
If you have been using this medicine regularly for several weeks or longer, do not change your dose or suddenly stop using it without checking with your doctor. Your doctor may want you to gradually reduce the amount you are using before stopping it completely. This may help prevent worsening of your condition and reduce the possibility of withdrawal symptoms, such as abdominal or stomach cramps, anxiety, fever, nausea, runny nose, sweating, tremors, or trouble sleeping.
This medicine may increase risk for muscle rigidity and movement. Tell your doctor if you or your child have stiff or rigid muscles after using this medicine.
Check with your doctor right away if you have anxiety, restlessness, a fast heartbeat, fever, sweating, muscle spasms, twitching, nausea, vomiting, diarrhea, or see or hear things that are not there. These may be symptoms of a serious condition called serotonin syndrome. Your risk may be higher if you also take certain other medicines that affect serotonin levels in your body.
Using this medicine while you are pregnant may cause neonatal withdrawal syndrome in your newborn babies. Tell your doctor right away if your baby has an abnormal sleep pattern, diarrhea, a high-pitched cry, irritability, shakiness or tremors, weight loss, vomiting, or fails to gain weight.
Using too much of this medicine may cause reduced infertility (unable to have children). Talk with your doctor before using this medicine if you plan to have children.
Do not eat grapefruit or drink grapefruit juice while you are using this medicine.
Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.
Serious side effects of Sublimaze
Along with its needed effects, fentanyl (the active ingredient contained in Sublimaze) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking fentanyl:
More common side effects
- chest pain or discomfort
- difficult or troubled breathing
- irregular, fast or slow, or shallow breathing
- lightheadedness, dizziness, or fainting
- pale or blue lips, fingernails, or skin
- severe muscle stiffness
- slow or irregular heartbeat
- unusual tiredness
Incidence not known
- blurred vision
- change in consciousness
- chills
- confusion
- cough
- difficulty with swallowing
- fast heartbeat
- feeling cold
- headache
- hives, itching, or skin rash
- inability to move the eyes
- inability to sit still
- increased blinking or spasms of the eyelid
- nervousness
- pounding in the ears
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- restlessness
- seeing, hearing, or feeling things that are not there
- sticking out the tongue when not meaning to
- sweating
- tightness in the chest
- uncontrolled twisting movements of the neck, trunk, arms, or legs
- unusual facial expressions
Other side effects of Sublimaze
Some side effects of fentanyl may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Incidence not known
- bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
- increased sweating
- redness of the skin
- vomiting
- welts
For healthcare professionals
Applies to fentanyl: buccal film, buccal tablet, compounding powder, injectable solution, intravenous solution, nasal spray, oral lozenge, oral transmucosal lozenge, sublingual spray, sublingual tablet, transdermal device, transdermal film extended release.
General adverse events
The most commonly reported adverse reactions included headache, nausea, vomiting, ,dizziness, and constipation.[Ref]
Nervous system
- Very common (10% or more): Somnolence, dizziness
- Common (1% to 10%): Sedation, pyrexia, fatigue, lethargy, tremor, headache, chills, irritability, malaise, confusion, abnormal thinking, anxiety, dysphoria
- Uncommon (0.1% to 1%): Hyperesthesia
- Very rare (less than 0.01%): Severe hemiplegic migraine
- Frequency not reported: Slurred speech, paresthesia, hypesthesia, tremor
- Postmarketing reports: Loss of consciousness, vertigo, coma, shock, convulsion[Ref]
Cases of seizures have occasionally been reported, but some investigators have suggested that the seizure-like events reported may have been episodes of fentanyl induced-rigidity.[Ref]
Cardiovascular
- Common (1% to 10%): Tachycardia
- Uncommon (0.1% to 1%): Sinus tachycardia, chest pain, hypertension, hypotension, palpitations
- Rare (less than 0.1%): Arrhythmias, cardiac arrest
- Frequency not reported: Syncope, vasodilation, bradycardia, bigeminy, myocardial infarct
- Postmarketing reports: Circulatory depression[Ref]
One report has suggested that epidural fentanyl may mask the pain of myocardial ischemia in patients treated with fentanyl for other reasons. Another report has suggested that QTc interval prolongation may occur in some patients receiving the related narcotic sufentanil. Another report has implicated fentanyl as a potential cause of pulsus alternans in a patient with aortic stenosis and congestive heart failure.
Nevertheless, fentanyl has been advocated by some as a satisfactory agent for coronary artery surgery.[Ref]
Gastrointestinal
- Very common (10% or more): Nausea (18%), vomiting (10%), constipation
- Common (1% to 10%): Dry mouth, abdominal distension, gastritis, dysphagia, dyspepsia, gastroesophageal reflux disease, ascites, hematemesis, taste perversion, abdominal pain, dehydration, anorexia, cachexia, vomiting, dry mouth, mouth ulcers/stomatitis, tongue edema
- Uncommon (0.1% to 1%): Abdomen enlarged, flatulence
- Rare (less than 0.1%): Choledochoduodenal sphincter spasm
- Frequency not reported: Diarrhea
- Postmarketing reports: Ileus, dental caries, tooth loss, gingival recession, gingivitis, gingival bleeding, lip edema, pharyngeal edema, gum bleeding, ulcer[Ref]
Genitourinary
- Uncommon (0.1% to 1%): Urinary retention
- Very rare (less than 0.01%): Priapism
- Frequency not reported: Urinary tract infection, urination impaired, hematuria, urinary urgency, dysuria[Ref]
Dermatologic
- Very common(10% or more): Iontophoretic transdermal system: Application site reaction-Erythema (14%)
- Common (1% to 10%): Application site irritation, pruritus
- Uncommon (0.1% to 1%): Hyperhidrosis, rash
- Rare (less than 0.1%): Systemic rashes
- Frequency not reported: vesicles, papules/pustules, dry and flaky skin, vesiculobullous rash wound site oozing/bleeding, wound site inflammation/erythema
- Postmarketing reports: Application site discharge, application site bleeding, application site infection, rash and scab, erosion, hyperesthesia, application site necrosis[Ref]
Approximately 60% of patients had some redness at the skin site 24-hours after removal of the iontophoretic transdermal system. The majority of skin events were categorized as mild, erythema and papules were observed; 2 patients had hyperpigmentation at the application site lasting 2 to 3 weeks; 3 patients had a rectangular mark at the application site which persisted for up to 3 months.[Ref]
Hypersensitivity
- Rare (less than 0.1%): Anaphylaxis[Ref]
Hematologic
- Common (1% to 10%): Anemia, neutropenia, lymphadenopathy, thrombocytopenia, leukopenia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood glucose increased, blood lactate increased, hypoalbuminemia, vasodilation[Ref]
The hemolysis observed may have been related to rapid injection of large volumes of hypotonic fentanyl (the active ingredient contained in Sublimaze) solution. The authors therefore recommend slower injection rates and/or mixture in isotonic fluid.[Ref]
Immunologic
- Uncommon (0.1% to 1%): Oral candidiasis, cellulitis, pneumonia, urinary tract infection, oral herpes, gastroenteritis, laryngitis
- Very rare (less than 0.01%): Recurrent herpes simplex infection following epidural administration[Ref]
Metabolic
- Common (1% to 10%): Asthenia, peripheral edema, weight decreased, hypokalemia, hyponatremia, hypocalcemia
- Very rare (less than 0.01%): Syndrome of inappropriate antidiuretic hormone
- Frequency not reported: abnormal healing, dehydration[Ref]
Endocrine
- Uncommon (0.1% to 1%): Hot flush[Ref]
Musculoskeletal
- Common (1% to 10%): Fall/accidental injury, back pain, arthralgia, joint swelling, muscular weakness, myoclonus, involuntary muscle contractions, muscle rigidity (involving the respiratory musculature including the glottis)
- Frequency not reported: Leg cramps, myalgia
- Postmarketing reports: Abnormal gait/incoordination[Ref]
Ocular
- Uncommon (0.1% to 1%): Vision blurred, dry eye
- Rare (less than 0.1%): Abnormal vision[Ref]
Psychiatric
- Common (1% to 10%): Depression, confusional state, hallucination, insomnia
- Uncommon (0.1% to 1%): Anxiety, agitation, restlessness, agitation, disorientation, abnormal dreams, depersonalization, depression, emotional lability, euphoria, delirium
- Frequency not reported: Nervousness[Ref]
Respiratory
- Common (1% to 10%): Dyspnea, rhinitis, yawning, respiratory distress, apnea, bradypnea, hypoventilation, respiratory depression
- Uncommon (0.1% to 1%): Cough, increased bronchial secretion, dysphonia, pharyngolaryngeal pain, wheezing, hypoxia, exertional dyspnea
- Very rare (less than 0.01%): Acute noncardiogenic pulmonary edema
- Frequency not reported: Asthma, hiccup, atelectasis, hyperventilation
- Postmarketing reports: Respiratory arrest[Ref]
See also:
Oxycodone
Oxycodone is an opioid analgesic used to treat moderate to severe pain; it has a high potential for ...
Tylenol
Tylenol is a pain reliever and a fever reducer used to treat many conditions such as headaches ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Amitriptyline
Amitriptyline is a tricyclic antidepressant used to treat depression and, off-label, conditions ...
Naproxen
Naproxen is a nonsteroidal anti-inflammatory drug used to treat pain or inflammation caused by ...
Tramadol
Tramadol is an opioid medication that may be used to treat moderate to moderately severe chronic ...
Paracetamol
Paracetamol (Panadol, Calpol, Alvedon) is a widely used over-the-counter painkiller and fever ...
Duloxetine
Duloxetine is a selective serotonin and norepinephrine reuptake inhibitor antidepressant used to ...
Promethazine
Promethazine is a phenothiazine and antihistamine used to treat allergies, motion sickness, nausea ...
References
1. (2006) "Product Information. Ionsys (fentanyl)." Ortho McNeil Pharmaceutical
2. Sebel PS, Bovill JG (1983) "Fentanyl and convulsions." Anesth Analg, 62, p. 858-9
3. Rao TL, Mummaneni N, El-Etr AA (1982) "Convulsions: an unusual response to intravenous fentanyl administration." Anesth Analg, 61, p. 1020-1
4. Comstock MK, Carter JG, Moyers JR, Stevens WC (1981) "Rigidity and hypercarbia associated with high dose fentanyl induction of anesthesia." Anesth Analg, 60, p. 362-3
5. Weinger MB, Swerdlow NR, Millar WL (1988) "Acute postoperative delirium and extrapyramidal signs in a previously healthy parturient." Anesth Analg, 67, p. 291-5
6. Goroszeniuk T, Albin M, Jones RM (1986) "Generalized grand mal seizure after recovery from uncomplicated fentanyl-etomidate anesthesia." Anesth Analg, 65, p. 979-81
7. Steinberg RB, Gilman DE, Johnson F, 3d (1992) "Acute toxic delirium in a patient using transdermal fentanyl." Anesth Analg, 75, p. 1014-6
8. Eisenach JC (1991) "Respiratory depression following intrathecal opioids." Anesthesiology, 75, p. 712
9. Palmer CM (1991) "Early respiratory depression following intrathecal fentanyl-morphine combination." Anesthesiology, 74, p. 1153-5
10. Hoien AO (1984) "Another case of grand mal seizure after fentanyl administration." Anesthesiology, 60, p. 387-8
11. Safwat AM, Daniel D (1983) "Grand mal seizure after fentanyl administration." Anesthesiology, 59, p. 78
12. Crawford RD, Baskoff JD (1980) "Fentanyl-associated delirium in man." Anesthesiology, 53, p. 168-9
13. Smith NT, Benthuysen JL, Bickford RG, Sanford TJ, Blasco T, Duke PC, Head N, Dec-Silver H (1989) "Seizures during opioid anesthetic induction--are they opioid-induced rigidity?" Anesthesiology, 71, p. 852-62
14. Mirenda J, Tabatabai M, Wong K (1988) "Delayed and prolonged rigidity greater than 24 h following high-dose fentanyl anesthesia." Anesthesiology, 69, p. 624-5
15. Arandia HY, Patil VU (1987) "Glottic closure following large doses of fentanyl." Anesthesiology, 66, p. 574-5
16. Benthuysen JL, Stanley TH (1985) "Concerning the possible nature of reported fentanyl seizures." Anesthesiology, 62, p. 205
17. Streisand JB, Bailey PL, LeMaire L, Ashburn MA, Tarver SD, Varvel J, Stanley TH (1993) "Fentanyl-induced rigidity and unconsciousness in human volunteers. Incidence, duration, and plasma concentrations." Anesthesiology, 78, p. 629-34
18. Hays LR, Stillner V, Littrell R (1992) "Fentanyl dependence associated with oral ingestion." Anesthesiology, 77, p. 819-20
19. Brockway MS, Noble DW, Sharwood-Smith GH, McClure JH (1990) "Profound respiratory depression after extradural fentanyl." Br J Anaesth, 64, p. 243-5
20. Harper MH, Hickey RF, Cromwell TH, Linwood S (1976) "The magnitude and duration of respiratory depression produced by fentanyl and fentanyl plus droperidol in man." J Pharmacol Exp Ther, 199, p. 464-8
21. Varrassi G, Celleno D, Capogna G, et al. (1992) "Ventilatory effects of subarachnoid fentanyl in the elderly." Anaesthesia, 47, p. 558-62
22. Noble DW, Morrison LM, Brockway MS, Mcclure JH (1994) "Respiratory depression after extradural fentanyl." Br J Anaesth, 72, p. 251
23. Jackson FW (1994) "Fentanyl and the wooden chest." Gastroenterology, 106, p. 820-1
24. Sandler AN, Baxter AD, Katz J, Samson B, Friedlander M, Norman P, Koren G, Roger S, Hull K, Klein J (1994) "A double-blind, placebo-controlled trial of transdermal fentanyl after abdominal hysterectomy: analgesic, respiratory, and pharmacokinetic effects." Anesthesiology, 81, p. 1169-80
25. Bernstein KJ, Klausner MA (1994) "Potential dangers related to transdermal fentanyl (duragesic(r)) when used for postoperative pain." Dis Colon Rectum, 37, p. 1339-40
26. Gil-Gouveia R, Wilkinson PA, Kaube H (2004) "Severe hemiplegic migraine attack precipitated by fentanyl sedation for esophagogastroscopy." Neurology, 63, p. 2446-7
27. Cerner Multum, Inc. "UK Summary of Product Characteristics."
28. Hilgenberg JC, Johantgen WC (1980) "Bradycardia after intravenous fentanyl during subarachnoid anesthesia." Anesth Analg, 59, p. 162-3
29. Oden RV, Karagianes TG (1991) "Postoperative myocardial ischemia possibly masked by epidural fentanyl analgesia." Anesthesiology, 74, p. 941-3
30. Blair JR, Pruett JK, Crumrine RS, Balser JJ (1987) "Prolongation of QT interval in association with the administration of large doses of opiates." Anesthesiology, 67, p. 442-3
31. Sebel PS, Bovill JG, Boekhorst RA, Rog N (1982) "Cardiovascular effects of high-dose fentanyl anaesthesia." Acta Anaesthesiol Scand, 26, p. 308-15
32. Freeman AB, Steinbrook RA (1985) "Recurrence of pulsus alternans after fentanyl injection in a patient with aortic stenosis and congestive heart failure." Can Anaesth Soc J, 32, p. 654-7
33. McCammon RL, Viegas OJ, Stoelting RK, Dryden GE (1978) "Naloxone reversal of choledochoduodenal sphincter spasm associated with narcotic administration." Anesthesiology, 48, p. 437
34. Gaskey NJ, Ferriero L, Pournaras L, Seecof J (1986) "Use of fentanyl markedly increases nausea and vomiting in gynecological short stay patients." AANA J, 54, p. 309-11
35. Sosis M (1985) "Fentanyl and emesis." Can Anaesth Soc J, 32, p. 314-5
36. White MJ, Berghausen EJ, Dumont SW, Tsueda K, Schroeder JA, Vogel RL, Heine MF, Huang KC (1992) "Side effects during continuous epidural infusion of morphine and fentanyl." Can J Anaesth, 39, p. 576-82
37. Chin JL, Sharpe JR (1983) "Priapism and anesthesia: new considerations." J Urol, 130, p. 371
38. "Multum Information Services, Inc. Expert Review Panel"
39. Stoukides CA, Stegman M (1992) "Diffuse rash associated with transdermal fentanyl." Clin Pharm, 11, p. 222
40. Zucker-Pinchoff B, Ramanathan S (1989) "Anaphylactic reaction to epidural fentanyl." Anesthesiology, 71, p. 599-601
41. Bennett MJ, Anderson LK, McMillan JC, Ebertz JM, Hanifin JM, Hirshman CA (1986) "Anaphylactic reaction during anaesthesia associated with positive intradermal skin test to fentanyl." Can Anaesth Soc J, 33, p. 75-8
42. Furuya H, Okumura F (1986) "Hemolysis after administration of high-dose fentanyl." Anesth Analg, 65, p. 207-8
43. Valley MA, Bourke DL, McKenzie AM (1992) "Recurrence of thoracic and labial herpes simplex virus infection in a patient receiving epidural fentanyl." Anesthesiology, 76, p. 1056-7
44. Kokko H, Hall PD, Afrin LB (2002) "Fentanyl-associated syndrome of inappropriate antidiuretic hormone secretion." Pharmacotherapy, 22, p. 1188-92
45. Ananthanarayan C (1990) "Tussive effect of fentanyl." Anaesthesia, 45, p. 595
46. Bohrer H, Fleischer F, Werning P (1990) "Tussive effect of a fentanyl bolus administered through a central venous catheter." Anaesthesia, 45, p. 18-21
47. Soto J, Sacristan JA, Alsar MJ (1992) "Pulmonary oedema due to fentanyl?." Anaesthesia, 47, p. 913-4
48. Phua WT, Teh BT, Jong W, Lee TL, Tweed WA (1991) "Tussive effect of a fentanyl bolus." Can J Anaesth, 38, p. 330-4
49. Tweed WA, Dakin D (2001) "Explosive coughing after bolus fentanyl injection." Anesth Analg, 92, p. 1442-3
Frequently asked questions
- Which drugs cause opioid-induced constipation?
- How long does Fentanyl stay in your system?
- Why is fentanyl so dangerous?
- Carfentanil vs Fentanyl: Which is more dangerous?
- Fentanyl test strips: where to get & how to use?
- Which painkiller should you use?
- What are the symptoms of a fentanyl overdose?
- How does fentanyl compare to heroin or other opiates?
More about Sublimaze (fentanyl)
- Check interactions
- Compare alternatives
- Reviews (6)
- Latest FDA alerts (14)
- Dosage information
- During pregnancy
- Drug class: Opioids (narcotic analgesics)
- Breastfeeding
Patient resources
Other brands
Duragesic, Actiq, Fentora, Subsys, ... +4 more
Professional resources
Other brands
Duragesic, Actiq, Fentora, Subsys, ... +2 more
Related treatment guides
Further information
Sublimaze side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.